LON:NIOX NIOX Group (NIOX) Share Price, News & Analysis → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free NIOX Stock Alerts GBX 70.40 +0.40 (+0.57%) (As of 05/28/2024 ET) Add Compare Share Share Today's Range 69.48▼ 7450-Day Range 63.40▼ 75.2052-Week Range 54▼ 75.60Volume125,587 shsAverage Volume922,109 shsMarket Capitalization£298.52 millionP/E Ratio3,520.00Dividend Yield1.42%Price TargetGBX 77 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsDividendInsider Trades Get NIOX Group alerts: Email Address Ad InvestorPlaceMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… About NIOX GroupNIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.Read More NIOX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NIOX Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive NIOX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NIOX Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 6/24 Dividend5/23/2024Today5/28/2024Dividend Payable6/24/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolLON:NIOX CUSIPN/A CIKN/A Webinvestors.niox.com Phone44 18 6540 5560FaxN/AEmployees92Year FoundedN/APrice Target and Rating Average Stock Price TargetGBX 77 High Stock Price TargetGBX 77 Low Stock Price TargetGBX 77 Potential Upside/Downside+9.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)GBX 0.02 Trailing P/E Ratio3,530.00 Forward P/E Ratio57.70 P/E GrowthN/ANet Income£9.50 million Net Margins29.08% Pretax MarginN/A Return on Equity11.47% Return on Assets3.03% Debt Debt-to-Equity Ratio1.31 Current Ratio4.65 Quick Ratio1.94 Sales & Book Value Annual Sales£36.80 million Price / Sales8.11 Cash FlowGBX 6.28 per share Price / Cash Flow11.21 Book ValueGBX 20 per share Price / Book3.52Miscellaneous Outstanding Shares424,040,000Free FloatN/AMarket Cap£298.52 million OptionableNot Optionable Beta0.90 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Ian Roy Johnson (Age 71)Executive Chairman Comp: $649kMr. Michael Roy David Roller A.C.A. (Age 59)BA (Hons), CFO & Director Comp: $507kMr. Jonathan Emms (Age 61)COO & Executive Director Comp: $652kMs. Nina KatariaSenior Vice President Global Human ResourcesMr. Tom ScacciaSenior Vice President of Americas & Research BusinessMs. Sarah Elizabeth DuncanCompany SecretaryMore ExecutivesKey CompetitorsMaxCyteLON:MXCTEKF DiagnosticsLON:EKFCreo Medical GroupLON:CREOHorizon Discovery Group plc (HZD.L)LON:HZDOxford BiomedicaLON:OXBView All CompetitorsInsidersMichael R D RollerSold 30,000 sharesTotal: £1.92 M ($64.00/share)Jonathan EmmsSold 31,250 sharesTotal: £2 M ($64.00/share)Ian JohnsonSold 223,784 sharesTotal: £13.87 M ($62.00/share)View All Insider Transactions NIOX Stock Analysis - Frequently Asked Questions Should I buy or sell NIOX Group stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NIOX Group in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" NIOX shares. View NIOX analyst ratings or view top-rated stocks. What is NIOX Group's stock price target for 2024? 1 brokerages have issued 1 year price objectives for NIOX Group's shares. Their NIOX share price targets range from GBX 77 to GBX 77. On average, they anticipate the company's stock price to reach GBX 77 in the next year. This suggests a possible upside of 9.4% from the stock's current price. View analysts price targets for NIOX or view top-rated stocks among Wall Street analysts. How have NIOX shares performed in 2024? NIOX Group's stock was trading at GBX 67 at the beginning of 2024. Since then, NIOX stock has increased by 5.1% and is now trading at GBX 70.40. View the best growth stocks for 2024 here. How often does NIOX Group pay dividends? What is the dividend yield for NIOX Group? NIOX Group announced a dividend on Thursday, April 4th. Stockholders of record on Thursday, May 23rd will be given a dividend of GBX 1 per share on Monday, June 24th. This represents a dividend yield of 1.58%. The ex-dividend date is Thursday, May 23rd. The official announcement can be seen at this link. Read our dividend analysis for NIOX. Is NIOX Group a good dividend stock? NIOX Group (LON:NIOX) pays an annual dividend of GBX 1 per share and currently has a dividend yield of 1.43%. The dividend payout ratio is 5,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for NIOX. How do I buy shares of NIOX Group? Shares of NIOX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:NIOX) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaWARNING about the death of the U.S. dollar…Colonial MetalsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock Digest Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NIOX Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
